Abstract
This year we start the 10th year of Therapeutic Hypothermia and Temperature Management. I am happy to report that the Journal continues to expand in terms of its reporting of the most timely information regarding the use of therapeutic hypothermia and targeted temperature management in both experimental as well as clinical investigations. High-end articles important to the field continue to be received and we greatly appreciate our editorial board members and scientific community for contributing to the advancement of this important publication. In this issue of the Journal, three expert panel discussions are included that resulted from presentations during our 2019 Therapeutic Hypothermia and Temperature Management Symposium in Miami. One expert panel discussion reviewed current advances in the use of therapeutic hypothermia in various clinical situations. This panel was moderated by Dr. Justin Lundbye and Drs. Neeraj Badjatia, Kees H. Polderman, and Patrick Lyden provided outstanding presentations on various topics of interest to the readership of the Journal. In another panel discussion moderated by Dr. Graham Nichol, intraoperative temperature management procedures were discussed with Drs. Jason Bartos, Joseph E. Tonna, and Markus Ferrari providing their expertise in the area of temperature management procedures. Finally in the third panel, studies targeting clinical conditions such as stroke and traumatic brain injury reviewed the current information in the use of therapeutic hypothermia targeting these important clinical problems.
In addition to these expert panel discussions, a state-of-the-art review on sinus-bradycardia during targeted temperature management is provided by Dr. Kyriazopoulou and colleagues. This review is followed by seven original articles that provide new information on a variety of subjects. Dr. Ianosi and colleagues report on an observational study using nonopioid analgesics and antipyretics after subarachnoid hemorrhage and the effects on hemodynamics and systemic and brain temperature. In another study, the impact of care on resource utilization and quality of care of patients undergoing therapeutic hypothermia is presented by Dr. Allen. Dr. Liow and colleagues report on a secondary analysis of morphine used during therapeutic hypothermia after neonatal encephalopathy. Care after resuscitation within the United Kingdom's first dedicated multidisciplinary program for survivals of out-of-hospital cardiac care is provided by Dr. Mion and colleagues. Dr. Rosenthal and colleagues describe a prospective clinical trial measuring the effects of cardiopulmonary bypass under mild hypothermia and its regulation of cold-shock protein RBM3. In patients with temperature management, Dr. Sakurai and colleagues describe effects of brain oxygen measurement by regional oxygen saturation in postcardiac arrest patients. Finally, Dr. Xie and colleagues describe the impact of targeted temperature management on serum electrolytes and blood glucose. This issue also includes a new Arctic Challenge that provides a variety of questions and answers to current questions in the field of therapeutic hypothermia and temperature management. Together these articles and roundtable discussions should be of interest to our readers, and we hope you continue to enjoy the information that is being published in these various issues of the Journal.